The IL-2-based immunocytokines that showed positive results in preclinical lymphoma studies include L19-IL2 in NHL, HI-Leu 16-IL2 in lymphoma and HRS3scFv-IL12-Fc-IL12 in Hodgkin lymphoma. The gene discussed is IL2; the disease is Hodgkins lymphoma.